Daiwa Securities Group
AUTL

Daiwa Securities Group’s Autolus Therapeutics AUTL Stock Holding History

Daiwa Securities Group’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-575
Closed -$1K – 1212
2025
Q4 		$1K Hold
575
– – ﹤0.01% 1339
2025
Q3 		$1K Hold
575
– – ﹤0.01% 1300
2025
Q2 		$1K Sell
575
-22,352
-97% -$37K ﹤0.01% 1249
2025
Q1 		$36K Sell
22,927
-816
-3% -$1.66K ﹤0.01% 1043
2024
Q4 		$56K Buy
23,743
+8,479
+56% +$28.7K ﹤0.01% 1056
2024
Q3 		$55K Sell
15,264
-604
-4% -$2.41K ﹤0.01% 1061
2024
Q2 		$55K Buy
15,868
+15,293
+2,660% +$66K ﹤0.01% 1091
2024
Q1 		$4K Hold
575
– – ﹤0.01% 1217
2023
Q4 		$4K Buy
+575
New +$2.19K ﹤0.01% 1218
2022
Q4 		– Sell
-74
Closed – – 1320
2022
Q3 		$0 Hold
74
– – ﹤0.01% 1339
2022
Q2 		$0 Hold
74
– – ﹤0.01% 1356
2022
Q1 		$0 Hold
74
– – ﹤0.01% 1377
2021
Q4 		$0 Hold
74
– – ﹤0.01% 1394
2021
Q3 		$0 Hold
74
– – ﹤0.01% 1316
2021
Q2 		$0 Hold
74
– – ﹤0.01% 1258
2021
Q1 		$0 Hold
74
– – ﹤0.01% 1269
2020
Q4 		$1K Sell
74
-94
-56% -$1K ﹤0.01% 1165
2020
Q3 		$2K Hold
168
– – ﹤0.01% 1137
2020
Q2 		$1K Hold
168
– – ﹤0.01% 1180
2020
Q1 		$1K Hold
168
– – ﹤0.01% 1183
2019
Q4 		$2K Hold
168
– – ﹤0.01% 1156
2019
Q3 		$2K Buy
168
+53
+46% +$700 ﹤0.01% 1121
2019
Q2 		$2K Hold
115
– – ﹤0.01% 1144
2019
Q1 		$4K Sell
115
-85
-43% -$2.42K ﹤0.01% 1089
2018
Q4 		$7K Buy
+200
New +$6.58K ﹤0.01% 1022

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Daiwa Securities Group's AUTL Position: Q1 2026 in Review

Daiwa Securities Group sold out of Autolus Therapeutics (AUTL) in Q1 2026, closing a stake of 575 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in AUTL in Q4 2018 and held it in 25 quarters. The position peaked at $56K in Q4 2024. 84 funds tracked by Wall St. Rank hold AUTL as of Q1 2026.

  • Daiwa Securities Group reported no remaining Autolus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 575 Autolus Therapeutics shares in Q1 2026, an estimated $1K.
  • Daiwa Securities Group first reported a position in Autolus Therapeutics in Q4 2018 and held it in 25 quarters.
  • Daiwa Securities Group's Autolus Therapeutics position peaked at $56K in Q4 2024.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.